Congress Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.41M | Sell |
|
|||||
|
2025
Q2 | $3.33M | Buy |
|
|||||
|
2025
Q1 | $2.32M | Sell |
|
|||||
|
2024
Q4 | $2.71M | Buy |
|
|||||
|
2024
Q3 | $3.09M | Buy |
|
|||||
|
2024
Q2 | $3.46M | Sell |
|
|||||
|
2024
Q1 | $4.4M | Buy |
|
|||||
|
2023
Q4 | $2.52M | Buy |
|
|||||
|
2023
Q3 | $1.83M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $2.56M | Buy |
|
|||||
|
2020
Q3 | $1.38M | Hold |
|
|||||
|
2020
Q2 | $1.21M | Buy |
|
|||||
|
2020
Q1 | $685K | Hold |
|
|||||
|
2019
Q4 | $984K | Sell |
|
|||||
|
2019
Q3 | $1.77M | Hold |
|
|||||
|
2019
Q2 | $2.03M | Buy |
|
|||||
|
2019
Q1 | $699K | Buy |
|